Koninklijke Philips (PHG) Cash from Operations Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.68% |
| Dec 31, 2025 | 0.74% |
| Sep 30, 2025 | -10.66% |
| Jun 30, 2025 | -26.65% |
| Mar 31, 2025 | -47.20% |
| Dec 31, 2024 | 5.99% |
| Sep 30, 2024 | -11.85% |
| Jun 30, 2024 | -26.21% |
| Mar 31, 2024 | -68.73% |
| Dec 31, 2023 | -7.05% |
| Sep 30, 2023 | 11.55% |
| Jun 30, 2023 | -1.07% |
| Mar 31, 2023 | 13.92% |
| Dec 31, 2022 | 41.78% |
| Sep 30, 2022 | -20.34% |
| Jun 30, 2022 | -22.83% |
| Mar 31, 2022 | -22.84% |
| Dec 31, 2021 | 18.97% |
| Sep 30, 2021 | 0.87% |
| Jun 30, 2021 | 18.26% |
| Mar 31, 2021 | 103.74% |
| Dec 31, 2020 | 4.06% |
| Sep 30, 2020 | 23.40% |
| Jun 30, 2020 | 52.88% |
| Mar 31, 2020 | 22.54% |
| Dec 31, 2019 | -6.47% |
| Jun 30, 2018 | -3.37% |
| Mar 31, 2018 | 18.89% |
| Dec 31, 2017 | -24.39% |
| Sep 30, 2017 | -23.03% |
| Jun 30, 2017 | -3.33% |
| Mar 31, 2017 | -3.88% |
| Dec 31, 2016 | -27.27% |
| Sep 30, 2016 | 20.41% |
| Jun 30, 2016 | 17.91% |
| Mar 31, 2016 | 15.06% |
| Dec 31, 2015 | -7.16% |
| Sep 30, 2015 | 1.59% |
| Jun 30, 2015 | -16.04% |
| Mar 31, 2015 | -20.06% |
| Dec 31, 2014 | 6.76% |